Emergent BioSolutions
EBS
#6766
Rank
NZ$1.09 B
Marketcap
NZ$20.60
Share price
-1.24%
Change (1 day)
32.42%
Change (1 year)

Number of shares outstanding for Emergent BioSolutions (EBS)

Number of shares outstanding as of December 2025 : 53,200,000

According to Emergent BioSolutions 's latest financial reports and stock price the company's current number of shares outstanding is 53,200,000. At the end of 2025 the company had 53,200,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Emergent BioSolutions from 2004 to 2025

Shares Outstanding at the end of each year

Year Shares Outstanding Change
202553.2 M-1.85%
202454.2 M4.43%
202351.9 M4.01%
202249.9 M-6.73%
202153.5 M0.75%
202053.1 M2.71%
201951.7 M1.57%
201850.9 M14.98%
201744.26 M9.26%
201640.51 M3.62%
201539.1 M4.02%
201437.59 M3.23%
201336.41 M1.46%
201235.89 M0.1%
201135.85 M14.55%
201031.3 M2.61%
200930.5 M2.31%
200829.81 M0.27%
200729.73 M32.83%
200622.38 M12.34%
200519.93 M5.34%
200418.91 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Merck
MRK
2,487,348,810 4,575.47%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
71,604,956 34.60%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
2,017,000,000 3,691.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
66,420,000 24.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
5,685,000,000 10,586.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1,147,000,000 2,056.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
4,329,649-91.86%๐Ÿ‡บ๐Ÿ‡ธ USA